Literature DB >> 21168446

Sensorimotor and cognitive function of a NEFL(P22S) mutant model of Charcot-Marie-Tooth disease type 2E.

Mohammed Filali1, Florence Dequen, Robert Lalonde, Jean-Pierre Julien.   

Abstract

Charcot-Marie-Tooth (CMT) disease is the most frequently encountered hereditary disease causing sensorimotor neuropathies and slowly progressive muscle weakness and atrophy. The P22S mutation of the NEFL gene encoding the light polypeptide neurofilament (NFL) is associated with CMT. To understand more clearly the pathogenesis of sensorimotor dysfunction in CMT, we generated transgenic mice with the NEFL(P22S) mutation under the tet-off tetracycline regulated system with involvement of the Thy1 neuron-specific promoter. NEFL(P22S) transgenic mice exhibited extended duration of the hindlimb clasping response and gait anomalies, as well as sensorimotor deficits in stationary beam and suspended bar tests. In addition, the NEFL(P22S) mice were deficient in the reversal phase of left-right discrimination learning in a water maze. This model mimics some aspects of human CMT pathology and provides an opportunity of ameliorating CMT symptoms with experimental therapies.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168446     DOI: 10.1016/j.bbr.2010.12.022

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  Exacerbation of Charcot-Marie-Tooth type 2E neuropathy following traumatic nerve injury.

Authors:  Eric Villalón; Jeffrey M Dale; Maria Jones; Hailian Shen; Michael L Garcia
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

2.  Expressing hNF-LE397K results in abnormal gaiting in a transgenic model of CMT2E.

Authors:  J M Dale; E Villalon; S G Shannon; D M Barry; R M Markey; V B Garcia; M L Garcia
Journal:  Genes Brain Behav       Date:  2012-02-23       Impact factor: 3.449

3.  Muscle spindle alterations precede onset of sensorimotor deficits in Charcot-Marie-Tooth type 2E.

Authors:  E Villalón; M R Jones; C Sibigtroth; S J Zino; J M Dale; D S Landayan; H Shen; D D W Cornelison; M L Garcia
Journal:  Genes Brain Behav       Date:  2016-10-11       Impact factor: 3.449

4.  Behavioral and molecular exploration of the AR-CMT2A mouse model Lmna (R298C/R298C).

Authors:  Yannick Poitelon; Serguei Kozlov; Jerôme Devaux; Jean-Michel Vallat; Marc Jamon; Pierre Roubertoux; Sitraka Rabarimeriarijaona; Cécile Baudot; Tarik Hamadouche; Colin L Stewart; Nicolas Levy; Valérie Delague
Journal:  Neuromolecular Med       Date:  2012-02-14       Impact factor: 3.843

5.  Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1C.

Authors:  Samuel M Lee; Di Sha; Anum A Mohammed; Seneshaw Asress; Jonathan D Glass; Lih-Shen Chin; Lian Li
Journal:  Hum Mol Genet       Date:  2013-01-28       Impact factor: 6.150

6.  Loss of the E3 ubiquitin ligase LRSAM1 sensitizes peripheral axons to degeneration in a mouse model of Charcot-Marie-Tooth disease.

Authors:  Laurent P Bogdanik; James N Sleigh; Cong Tian; Mark E Samuels; Karen Bedard; Kevin L Seburn; Robert W Burgess
Journal:  Dis Model Mech       Date:  2013-03-08       Impact factor: 5.758

7.  Brain region-specific altered expression and association of mitochondria-related genes in autism.

Authors:  Ayyappan Anitha; Kazuhiko Nakamura; Ismail Thanseem; Kazuo Yamada; Yoshimi Iwayama; Tomoko Toyota; Hideo Matsuzaki; Taishi Miyachi; Satoru Yamada; Masatsugu Tsujii; Kenji J Tsuchiya; Kaori Matsumoto; Yasuhide Iwata; Katsuaki Suzuki; Hironobu Ichikawa; Toshiro Sugiyama; Takeo Yoshikawa; Norio Mori
Journal:  Mol Autism       Date:  2012-11-01       Impact factor: 7.509

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.